Cover image of the article: Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE

Image Credit:Int J Endocrinol Metab

Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE

Authors

Santosh kumar Gupta1,*, Suhas Singla1, Nishikant A Damle1, Krishankant Agarwal1, Chandersekhar Bal1
1Department of Nuclear Medicine, All India Institute of Medical Sciences, santoshaiims@gmail.com, India
*Corresponding Author: Department of Nuclear Medicine, All India Institute of Medical Sciences, santoshaiims@gmail.com, India. Tel: +91-1126593530. Fax: +91-1126588993. Email: santoshaiims@gmail.com

International Journal of Endocrinology and Metabolism:Vol. 10, issue 4; 629-633
Published online:Sep 29, 2012
Article type:Case Report
Received:Feb 01, 2012
Accepted:May 06, 2012
How to Cite:kumar Gupta S, Singla S, A Damle N, Agarwal K, Bal C. Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE. Int J Endocrinol Metab. 2012;10(4):. doi: https://doi.org/10.5812/ijem.4313

Abstract

Abstract:

MEN-I is a rare genetic disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary gland, and pancreatic islet cells. We present a case of MEN-I syndrome diagnosed using predominantly nuclear medicine imaging followed by radionuclide therapy, thus emphasizing the role of nuclear imaging in diagnosing and treating MEN-I.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Oct
2013
Depicting Medullary Thyroid Cancer Recurrence: The Past and the Future of Nuclear Medicine Imaging

Depicting Medullary Thyroid Cancer Recurrence: The Past and the Future of Nuclear Medicine Imaging

Evangelia Skoura

Skoura E. Depicting Medullary Thyroid Cancer Recurrence: The Past and the Future of Nuclear Medicine Imaging. Int J Endocrinol Metab. 2013;11(4):e8156. doi: https://doi.org/10.5812/ijem.8156

3
May
2020
A Case Report of Paraganglioma: A Diagnosis Not to Be Missed

A Case Report of Paraganglioma: A Diagnosis Not to Be Missed

Mohammad Mozaffar,
Parima Safe,
Tayebeh Rostami,
Barmak Gholizadeh,
Adel Zeinalpour

Mozaffar M, Safe P, Rostami T, Gholizadeh B, Zeinalpour A. A Case Report of Paraganglioma: A Diagnosis Not to Be Missed. Int J Cancer Manag. 2020;13(5):e99817. doi: https://doi.org/10.5812/ijcm.99817

27
Jun
2022
RET T244I Germline Variant Mutation in a Patient with Pancreatic Paraganglioma and Primary Hyperparathyroidism

RET T244I Germline Variant Mutation in a Patient with Pancreatic Paraganglioma and Primary Hyperparathyroidism

Minha Kim,
Krist Aploks,
Susana Vargas-Pinto,
Xiang Dong

Kim M, Aploks K, Vargas-Pinto S, Dong X. RET T244I Germline Variant Mutation in a Patient with Pancreatic Paraganglioma and Primary Hyperparathyroidism. Int J Endocrinol Metab. 2022;20(3):e121056. doi: https://doi.org/10.5812/ijem-121056

31
Oct
2021
Gallium-68-Labeled Prostate-Specific Membrane Antigen (68Ga-PSMA) Uptake in Renal Cell Carcinoma and Lung Adenocarcinoma: A Case Report

Gallium-68-Labeled Prostate-Specific Membrane Antigen (68Ga-PSMA) Uptake in Renal Cell Carcinoma and Lung Adenocarcinoma: A Case Report

Abtin Doroudinia,
Payam Mehrian,
Maedeh Forghani

Doroudinia A, Mehrian P, Forghani M. Gallium-68-Labeled Prostate-Specific Membrane Antigen (68Ga-PSMA) Uptake in Renal Cell Carcinoma and Lung Adenocarcinoma: A Case Report. I J Radiol. 2021;18(4):e115962. doi: https://doi.org/10.5812/iranjradiol.115962

19
May
2022
Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients

Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients

Abtin Doroudinia,
Najmeh Darvishian,
Mehrdad Bakhshayesh Karam,
Habib Emami

Doroudinia A, Darvishian N, Bakhshayesh Karam M, Emami H. Evaluation of the Relationship Between Prostate-Specific Antigen Levels, Gleason Scores, and 68Ga-PSMA PET/CT Scan Findings in Prostate Cancer Patients. I J Radiol. 2022;19(1):e122440. doi: https://doi.org/10.5812/iranjradiol-122440

More by these authors

Santosh kumar GuptaPubMedScholar
Suhas SinglaPubMedScholar
Nishikant A DamlePubMedScholar
Krishankant AgarwalPubMedScholar
Chandersekhar BalPubMedScholar
Share
Cited by
Metrics